SCHEMBL3369965

SCHEMBL3369965

CCOC(=O)C(Cc1ccc(O)c(F)c1)OC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.36
ALOX12 P18054 3/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
ESR1 P03372 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
RECQL P46063 2/20 0.36
KMT2A Q03164 2/20 0.36
HIF1A Q16665 2/20 0.36
HSD17B10 Q99714 2/20 0.36
NR3C1 P04150 2/20 0.36
FOS P01100 2/20 0.36
TTR P02766 2/20 0.36
JUN P05412 2/20 0.36
HSD17B1 P14061 2/20 0.36
HSD17B2 P37059 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374631 0.86 PPARA (0.41) PPARGCA12CA1CA2CA7
SCHEMBL12035914 0.83 PPARG (0.42) ALOX15ALOX12ALDH1A1KDM4EMEN1
SCHEMBL3369599 0.83 HSD17B2 (0.57) ALOX15ALOX12ALDH1A1KDM4EMEN1
SCHEMBL4335122 0.82 ALDH1A1 (0.37) ALOX15ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL4333251 0.81 ALOX15 (0.57) ALOX15ALOX12KDM4EMEN1CYP3A4
SCHEMBL3991226 0.80 ESR1 (0.45) ESR1SLC6A2PTGS2CA12CA1
SCHEMBL5384008 0.80 ESR1 (0.45) ESR1SLC6A2PTGS2CA12CA1
SCHEMBL11402716 0.80 SLC7A5 (0.48) ALOX15ALDH1A1KDM4EMEN1RECQL
SCHEMBL3372780 0.79 S1PR5 (0.47) ALDH1A1HPGDMAPK1LMNACYP2C9
SCHEMBL4332258 0.78 GRIA2 (0.42) ALDH1A1TP53MAPK1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537091-B1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS HOFFMANN LA ROCHE (CH) 2010-10-06 EP disclosed
EP-1537091-A1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2005-06-08 EP disclosed
US-6809110-B2 NONINSULIN DEPENDENT DIABETES; SUCH AS 2-ETHOXY-3-(4-(2-(5-METHYL-2-PHENYL-THIAZOL-4-YL)-ETHOXY)-BENZO(B)THIOPHEN-7-YL)-PROPIONIC ACID HOFFMANN-LA ROCHE INC. 2004-10-26 US disclosed
US-20040110807-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2004-06-10 US disclosed
WO-2004020420-A1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110807-A1 Thiazole derivatives SLC5A1, GPR119, INSR ALOX15 3239/4885ALOX12 3548/4885ALDH1A1 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.